Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
End Stage Renal Disease peptide trials
2 selected ClinicalTrials.gov records carrying the official condition label End Stage Renal Disease. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
2 selected records.
2 profiles.
2017–2022 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 32 selected PubMed records and 1 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern End Stage Renal Disease unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT00395291
PeptideScanner retained ClinicalTrials.gov record NCT00395291 at 2026-11-16T17:28:23.215Z. Its registry update date was 2017-02-20, and PeptideScanner's reviewed identity mapping was mk-677.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- February 20, 2017
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT03795558
PeptideScanner retained ClinicalTrials.gov record NCT03795558 at 2026-11-15T22:07:29.454Z. Its registry update date was 2022-03-23, and PeptideScanner's reviewed identity mapping was etelcalcetide.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- March 23, 2022
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Etelcalcetide · 2022-03-23
ClinicalTrials.gov record NCT03795558
Completed at the retained observation.
Open attributed record →MK-677 · 2017-02-20
ClinicalTrials.gov record NCT00395291
Completed at the retained observation.
Open attributed record →